Halozyme Therapeutics (NASDAQ:HALO) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Halozyme Therapeutics beat estimated earnings by 2.44%, reporting an EPS of $0.42 versus an estimate of $0.41.
Revenue was up $19.70 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.13 which was followed by a 1.42% increase in the share price the next day.
Here’s a look at Halozyme Therapeutics’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.42 | 0.40 | 0.32 | 0.53 |
| EPS Actual | 0.55 | 0.66 | 0.37 | 0.50 |
| Revenue Estimate | 101.94M | 103.16M | 84.88M | 120.16M |
| Revenue Actual | 115.83M | 136.46M | 89.02M | 121.70M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
